Bridged Group Competitors

We’re on our member’s side and have been looking after SA’s health for over 85 years. As a not-for-profit health fund, we’re passionate about our mission to improve the health and wellbeing of our members and our community. As well as providing great value health insurance, Health Partners own and operate SA’s largest private Dental practice, and have our own Optical stores. Members have the choice to be looked after by our team of clinical experts or choose their own provider. Health Partners members also enjoy generous benefits at our wide network of participating pharmacies and physiotherapists across South Australia. We’ve been awarded Australia’s Most Satisfied Customers by Canstar, 6 years running. Find out more at healthpartners.com.au

The Insight Group, with offices in Sydney and Melbourne, is a top Australian executive search and talent advisory firm. We bring extensive experience to assist organisations of all sizes with strategic recruitment needs across various sectors. Our approach is guided by key principles: client-centric collaboration, teamwork with specialised consulting teams (not commission-based), intelligence-driven research, and unwavering integrity with the utmost client and candidate confidentiality. We are a proud representative of Kestria, the world's largest alliance of boutique executive search firms in Australia. Kestria's reach currently spans 40+ countries and 90+ cities and counting. What sets us apart is our shared entrepreneurial spirit and drive to deliver excellence in executive search. Wherever the location, whatever the industry, we provide you with consistent first-class service. With globe-spanning connections and local knowledge you have a single point of contact for your international and local search requirements. We recognize that every search has differing requirements and tailor our approach to fit your needs. We've successfully completed 40,000+ searches for over 4,000 clients, serving everyone from game-changing start-ups to major global players. 50+ nationalities, 40+ languages spoken and 52% female-led businesses. This diversity enriches our awareness of cultural differences – and means we have every imaginable base covered with regards to industry, region and size of company.

BioMarker Strategies has developed the proprietary SnapPath® Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath® is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP® Functional Signaling Profiles, created using the SnapPath® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath® and the Functional Profiles it enables are available for Research Use in preclinical studies in tumorgraft and other model systems, and in early clinical studies to assess pharmacodynamic changes in the solid tumors of individual patients.